Biofrontera Inc. (BFRI) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - BFRI

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth11.75%

5Y CAGR17.21%

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth-80.00%

5Y CAGRN/A

10Y CAGRN/A

Equity

1Y Growth136.41%

5Y CAGR12.45%

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	11.7%	10.6%	13.3%	17.2%	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	9.5%	14.1%	15.7%	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	18.8%	18.9%	21.8%	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	19.0%	23.3%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	27.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - BFRI

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Biofrontera Inc.

Compare with peers

Explore

Growth Analysis - BFRI

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Biofrontera Inc.

Compare with peers

Explore